What i see, phase 1/2 FDA clinical trial, cancer drugs, cannabinoid drug, license agreement with Minnesota university, more trials planned, in the process of acquiring 4 high potential drugs, catalyst FDA results in June, patents, QB, 150m authorized shares and market cap below $2m.
There are much worse stocks, in fact there is not one which offers something similar and trades at this level and i doubt you find one with a cancer drug in phase 1/2 and results in June 2017!
No t-trade yesterday, no t-trade today, the trading could look better, but people accumulated at bid. VNDM is gone since yesterday, ARXS left also, there is only ARCA left.
Todays pr was good, but what we need are more buys, more volume or slower dilution. Thats the only issue here.
And btw there was no run. A person who posts there was a run, doesn´t know what a run is.
News 
Market Data 
Discover 
